BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 11873308)

  • 1. [Dualistic model of molecular pathogenesis in endometrial carcinoma].
    Lax SF
    Zentralbl Gynakol; 2002 Jan; 124(1):10-6. PubMed ID: 11873308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular carcinogenesis of endometrial cancer.
    Liu FS
    Taiwan J Obstet Gynecol; 2007 Mar; 46(1):26-32. PubMed ID: 17389185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses.
    Lax SF; Kurman RJ
    Verh Dtsch Ges Pathol; 1997; 81():228-32. PubMed ID: 9474874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Endometrial carcinoma and precursor lesions].
    Djordjević B; Stanojević Z
    Srp Arh Celok Lek; 2007; 135(3-4):230-4. PubMed ID: 17642468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetic changes in epithelial, stromal and mixed neoplasms of the endometrium.
    Lax SF
    Pathology; 2007 Feb; 39(1):46-54. PubMed ID: 17365822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
    Lax SF
    Virchows Arch; 2004 Mar; 444(3):213-23. PubMed ID: 14747944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theories of endometrial carcinogenesis: a multidisciplinary approach.
    Sherman ME
    Mod Pathol; 2000 Mar; 13(3):295-308. PubMed ID: 10757340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
    Lax SF; Pizer ES; Ronnett BM; Kurman RJ
    Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathology of functional and neoplastic changes in cervix and endometrium.
    Dallenbach-Hellweg G
    Verh Dtsch Ges Pathol; 1997; 81():240-4. PubMed ID: 9474876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
    Alvarez T; Miller E; Duska L; Oliva E
    Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma.
    Sutter C; Dallenbach-Hellweg G; Schmidt D; Baehring J; Bielau S; von Knebel Doeberitz M; Gebert J
    Int J Gynecol Pathol; 2004 Jan; 23(1):18-25. PubMed ID: 14668545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Precancerous lesion of the endometrium and endometrial morphology in patients with tamoxifen therapy].
    Schmidt D; Horn LC
    Zentralbl Gynakol; 2002 Jan; 124(1):3-9. PubMed ID: 11873307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic alterations and transformations in development and establishment of uterine endometrial carcinomas].
    Inoue M
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Aug; 45(8):751-62. PubMed ID: 8371006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and pathologic aspects of endometrial carcinogenesis.
    Hecht JL; Mutter GL
    J Clin Oncol; 2006 Oct; 24(29):4783-91. PubMed ID: 17028294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathology of Endometrial Carcinoma.
    Lax SF
    Adv Exp Med Biol; 2017; 943():75-96. PubMed ID: 27910065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma.
    Soslow RA; Wethington SL; Cesari M; Chiappetta D; Olvera N; Shia J; Levine DA
    Am J Surg Pathol; 2012 Dec; 36(12):1771-81. PubMed ID: 23154767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis in endometrial cancer.
    Caduff RF; Svoboda-Neumann SM; Johnston CM; Bartos RE; Frank TS
    Verh Dtsch Ges Pathol; 1997; 81():219-27. PubMed ID: 9474873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways.
    Lax SF; Kendall B; Tashiro H; Slebos RJ; Hedrick L
    Cancer; 2000 Feb; 88(4):814-24. PubMed ID: 10679651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K-ras mutation in tamoxifen-related endometrial polyps.
    Hachisuga T; Miyakawa T; Tsujioka H; Horiuchi S; Emoto M; Kawarabayashi T
    Cancer; 2003 Nov; 98(9):1890-7. PubMed ID: 14584071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometrium.
    Geels YP; van der Putten LJ; van Tilborg AA; Lurkin I; Zwarthoff EC; Pijnenborg JM; van den Berg-van Erp SH; Snijders MP; Bulten J; Visscher DW; Dowdy SC; Massuger LF
    Gynecol Oncol; 2015 May; 137(2):245-51. PubMed ID: 25773202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.